EUVIMEDScopri EUVIMED
Open access

Pulmonary Metastasizing Ameloblastomas Can Masquerade as Certain Bronchiolar Adenoma‐Like Tumor With Squamous Epithelial Metaplasia

Shengnan Zhao iD, Jianjun Li, Likun Hou iD, Yan Huang, Zhengwei Dong iD, Wei Wu, Wei Zhang, Chunyan Wu iD, Huikang Xie iD

Pathology International · 2026-07 · 76 (7)

DOI: 10.1111/pin.70155 ↗

At a glance

Journal article in Pathology International, published online on 2026-07-27. Written by Shengnan Zhao and 8 co-authors. Institution: Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China. Major MEDLINE topics: Lung Neoplasms, Ameloblastoma, Adenoma, Jaw Neoplasms. 19 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Bronchiolar adenoma (BA) is a generally benign peripheral lung neoplasm with a bilayered structure of basal and luminal cells. Recently, an increasing number of bronchiolar adenoma—like tumor with squamous epithelial metaplasia (BATSM) have been reported, raising the question of whether they represent variant subtypes of BA or potentially novel tumor entities. Pulmonary metastasis of ameloblastoma (MA) shares morphological similarities with BATSM, exhibiting TTF‐1/Napsin A‐positive luminal cells and P40/P63‐positive basal cells; this overlap can lead to misdiagnosis of MA as BATSM. We collected 5 MA and 10 BATSM cases, analyzing their morphology, immunohistochemistry, elastic fiber staining and molecular pathology. MA presents as well‐circumscribed bronchiole‐unrelated nodules with alveolar destruction, intraluminal serous secretions, and Calretinin‐positive stellate reticulum‐like cells. BATSM is bronchiole‐associated, preserves alveolar architecture, and is Calretinin‐negative with weak basal TTF‐1 positivity. 80% of MA cases harbored BRAF V600E mutations; 30% of BATSM cases exhibited EGFR exon 20 insertions. This study highlights the need for integrating clinical history, morphology, immunohistochemistry and molecular testing to avoid misdiagnosing MA as BATSM.

Subjects

MeSH terms (MEDLINE)

Lung NeoplasmsAmeloblastomaAdenomaJaw NeoplasmsHumansFemaleMetaplasiaMaleMiddle AgedAgedDiagnosis, DifferentialBiomarkers, TumorBronchiolesImmunohistochemistryProto-Oncogene Proteins B-rafAdult

Author keywords

ameloblastomabilayered architecturebronchiolar adenomawith squamous metaplasia

Substances

Biomarkers, TumorProto-Oncogene Proteins B-raf

Authors and institutions

  • Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

ORCID profiles: Shengnan Zhao, Likun Hou, Zhengwei Dong, Chunyan Wu, Huikang Xie

Funding

  • National Natural Science Foundation of China

Cite

APA

Zhao, S., Li, J., Hou, L., Huang, Y., Dong, Z., Wu, W., Zhang, W., Wu, C., & Xie, H. (2026). Pulmonary Metastasizing Ameloblastomas Can Masquerade as Certain Bronchiolar Adenoma‐Like Tumor With Squamous Epithelial Metaplasia. Pathology International, 76(7). https://doi.org/10.1111/pin.70155

Vancouver

Zhao S, Li J, Hou L, Huang Y, Dong Z, Wu W, et al. Pulmonary Metastasizing Ameloblastomas Can Masquerade as Certain Bronchiolar Adenoma‐Like Tumor With Squamous Epithelial Metaplasia. Pathology International. 2026;76(7). doi:10.1111/pin.70155

BibTeX
@article{Zhao2026,
  author = {Zhao, Shengnan and Li, Jianjun and Hou, Likun and Huang, Yan and Dong, Zhengwei and Wu, Wei and Zhang, Wei and Wu, Chunyan and Xie, Huikang},
  title = {Pulmonary Metastasizing Ameloblastomas Can Masquerade as Certain Bronchiolar Adenoma‐Like Tumor With Squamous Epithelial Metaplasia},
  journal = {Pathology International},
  year = {2026},
  volume = {76},
  number = {7},
  doi = {10.1111/pin.70155}
}
Start for free →